Diagnosis and management of autoimmune hepatitis

Authors


  • Potential conflict of interest: Dr. Krawitt is a consultant for GlaxoSmithKline and Intercept. Dr. Vierling received grants from Abbott, Conatus, Hyperion, Intercept, Ocera, Roche, Merck, Novartis, Sundise, Zymogenetics, GlobeImmune, Excalenz, and Pharmasset. Dr. Manns is a consultant for, advises, is on the speakers' bureau of, and received grants from Falk Pharma. He has received research support, lecture fees and took part in clinical trials for Falk Pharma GmbH, Freiburg, Germany, and Roche Pharma, Basel, Switzerland.

Ancillary